Glycosylated copper sulfide nanocrystals for targeted photokilling of bacteria in the near‐infrared II window

Photothermal and photodynamic therapies are established as alternative approaches to combating bacterial infections; however, the heat and reactive oxygen species generated by the photoagents act on both normal and bacterial cells. A targeting strategy is thus required to minimize side effects and e...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Hou, Shuai, Mahadevegowda, Surendra Hittanahalli, Mai, Van Cuong, Chan‐Park, Mary Bee Eng, Duan, Hongwei
مؤلفون آخرون: School of Chemical and Biomedical Engineering
التنسيق: مقال
اللغة:English
منشور في: 2020
الموضوعات:
الوصول للمادة أونلاين:https://hdl.handle.net/10356/138815
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
المؤسسة: Nanyang Technological University
اللغة: English
الوصف
الملخص:Photothermal and photodynamic therapies are established as alternative approaches to combating bacterial infections; however, the heat and reactive oxygen species generated by the photoagents act on both normal and bacterial cells. A targeting strategy is thus required to minimize side effects and enhance the antibacterial efficiency. Glycoconjugates specifically interacting with bacterial lectins have emerged as a new class of materials for targeting bacteria. In this paper, galactosylated plasmonic copper sulfide nanocrystals (Cu2−xS NCs) are used to target Pseudomonas aeruginosa via galactose–LecA interactions and kill the bacteria by simultaneous photothermal and photodynamic therapy. Galactosylated Cu2−xS NCs are obtained by functionalizing the nanocrystals with tri‐thiogalactoside glycoclusters. The excellent specificity of galactosylated nanoparticles toward LecA with a LecA‐deficient P. aeruginosa strain as the control is first demonstrated. Afterward, a laser in the near‐infrared II window is used to kill the bacteria, and the critical role of targeted binding in efficient killing of bacteria is highlighted. This approach can be readily generalized to the targeting of other pathogens which have highly specific carbohydrate‐binding lectins.